In a pre-clinical study, the IMC-A12 anti-IGF-1R antibody (ImClone Systems Incorporated, Somerville, NJ, USA) decreased LuCAP prostate cancer xenograft growth [8]. The gene discussed is IGF1R; the disease is Familial prostate cancer.